Key Points
- CEO Vincent Angotti bought 213,310 shares at an average price of $0.59 on March 13, spending $125,852.90 and boosting his ownership by 36.31% to 800,705 shares (valued ~ $472,416).
- Talphera stock jumped about 9.1% (opened $0.80) as the company — market cap ~$37.1M — reported a slight quarterly EPS beat, but analysts are mixed (Weiss reissued a "sell (d-)" while the consensus is "Hold" with a $6.00 target).
Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti bought 213,310 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average price of $0.59 per share, with a total value of $125,852.90. Following the purchase, the chief executive officer owned 800,705 shares of the company's stock, valued at $472,415.95. The trade was a 36.31% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Talphera Stock Up 9.1%
Shares of Talphera stock opened at $0.80 on Thursday. The firm has a market capitalization of $37.12 million, a P/E ratio of -2.15 and a beta of 0.47. Talphera, Inc. has a 52 week low of $0.38 and a 52 week high of $1.57. The firm's 50 day moving average is $0.88 and its two-hundred day moving average is $1.05.
Talphera (NASDAQ:TLPH - Get Free Report) last issued its quarterly earnings data on Monday, March 23rd. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.02. As a group, research analysts expect that Talphera, Inc. will post -0.64 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of Talphera in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Talphera presently has an average rating of "Hold" and a consensus target price of $6.00.
Get Our Latest Stock Analysis on Talphera
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Group One Trading LLC lifted its stake in Talphera by 3,224.0% in the third quarter. Group One Trading LLC now owns 30,415 shares of the company's stock valued at $27,000 after buying an additional 29,500 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Talphera in the third quarter valued at approximately $29,000. Persistent Asset Partners Ltd purchased a new position in shares of Talphera during the fourth quarter worth approximately $42,000. Mariner LLC grew its position in shares of Talphera by 132.0% during the fourth quarter. Mariner LLC now owns 58,000 shares of the company's stock worth $66,000 after acquiring an additional 33,000 shares during the last quarter. Finally, Dauntless Investment Group LLC acquired a new position in shares of Talphera in the 3rd quarter valued at $89,000. Institutional investors and hedge funds own 37.67% of the company's stock.
About Talphera
(
Get Free Report)
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
